DSM and Mitsubishi to Exchange Polycarbonate Businesses

DSM Engineering Plastics, a business group of the Netherlands-based Life Sciences and Materials Sciences company Royal DSM N.V., today announces that it has signed the contracts with Mitsubishi Chemical Corporation (MCC) enabling DSM to acquire MCC's Novamid polyamide business in exchange for DSM's Xantar polycarbonate business.

In May 2009 both companies already announced the signing of a memorandum of understanding for the intended swap. The transaction is subject to various external approvals. Closing is expected in Q2 2010.

For both companies the businesses they will add to their portfolios as a result of the intended swap of activities provide a strong strategic fit. DSM Engineering Plastics will be able to further reinforce its position as one of the globally leading producers of polyamide engineering plastics and expand its position in Japan, an important market where innovation and sustainability are driving growth.

A number of key employees of DSM's polycarbonate business will transfer to MCC. A number of employees of MCC will be seconded to DSM. It is also envisaged that MCC will establish an R&D unit at the Chemelot Research and Technology campus in Geleen (Netherlands).

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    DSM. (2019, February 10). DSM and Mitsubishi to Exchange Polycarbonate Businesses. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=20811.

  • MLA

    DSM. "DSM and Mitsubishi to Exchange Polycarbonate Businesses". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=20811>.

  • Chicago

    DSM. "DSM and Mitsubishi to Exchange Polycarbonate Businesses". AZoM. https://www.azom.com/news.aspx?newsID=20811. (accessed November 21, 2024).

  • Harvard

    DSM. 2019. DSM and Mitsubishi to Exchange Polycarbonate Businesses. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=20811.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.